Molecular Neurodegeneration Journal

We partner with BioMed Central's open access journal, Molecular Neurodegeneration (MN), which is the official journal of BrightFocus. The open access publishing model provides free articles to the general public, as well as scientists, clinicians, and other healthcare practitioners.

Molecular Neurodegeneration publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, such as Alzheimer's or Parkinson's,  and on the pre-clinical testing of potential therapies for these devastating diseases.

MN now ranks in the top 20 percent of neuroscience journals published worldwide with an impact score of 5.29.

Latest Articles from Molecular Neurodegeneration